July 24, 2014

Miami-Dade Business Profile

Biscayne Pharmaceuticals

| 8/14/2013
Samuel Reich and Andrew Schally (sitting)
Samuel Reich (standing) and Andrew Schally

For more than half a century, Nobel Prize-winning scientist and University of Miami faculty member Andrew Schally has been researching the hormones that stimulate growth in the body’s tissues. Now his work is being used by Miami-based Biscayne Pharmaceuticals, which was founded last year and licensed from UM the rights to Schally’s inventions related to that research. The company, which Schally works with as scientific adviser, is using his discovery to develop possible treatments for cancer and heart disease.

Biscayne Pharma got going after a $1.5-million investment from its co-founders and Miami Beach investment firm Reich Group, whose Managing Partner Samuel Reich joined Biscayne Pharma as CEO. “This is a breakthrough that will really transform the way we treat cancer,” Reich says.

Tags: Miami-Dade, Healthcare, Technology/Innovation

Digital Access

DIRECT DIGITAL ACCESS
Add digital to your current subscription, purchase a single ditgital issue, or start a new subscription to Florida Trend.

TABLE OF CONTENTS
An overview of the features and articles in this month's issue of Florida Trend.

ACCESS THIS ISSUE »

Florida Business News

Florida Trend Video Pick

Lazydays to star in new Travel Channel show about buying an RV
Lazydays to star in new Travel Channel show about buying an RV

Shopping for an RV at Lazydays RV SuperCenter in Seffner is the focus a new reality show premiering Sunday on the Travel Channel.

Earlier Videos | Viewpoints@FloridaTrend

Ballot Box

When Obamacare finally gets to the U.S. Supreme Court, do you believe it will stand, or be gutted?

  • The Affordable Care Act will stand
  • I believe it will be dealt serious, if not fatal, blows by highest court

See Results

Ballot Box
Subscribe